The global respiratory devices market growth is expanding at a CAGR of 8% from 2021 to 2030 and is expected to reach US$ 36 billion by 2030.
The global respiratory devices market growth is expanding at a CAGR of 8% from 2021 to 2030 and is expected to reach US$ 36 billion by 2030.
Respiratory devices are medical devices that are used to aid patients who are suffering from respiratory problems and cannot attain sufficient oxygen levels to sustain life.
Respiratory care devices are used for diagnosis, monitoring, and treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, tuberculosis, and pneumonia. These devices provide enhanced care to patients suffering from such acute and chronic respiratory diseases. The prevalence of respiratory diseases will continue to rise as our global population ages and the incidence of chronic diseases, such as COPD and asthma, increases exponentially. Hence the demand for respiratory devices will keep growing. In recent years patients with respiratory diseases use various devices, which help the removal of mucus from the airways and the improvement of pulmonary function.
Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38758
The growth of the global respiratory devices market is majorly driven by the high prevalence of respiratory diseases, rising aging population across the globe, high prevalence of smoking, rising urbanization and pollution levels, increasing incidence of preterm births, and lifestyle changes. Infectious respiratory diseases directly drive demand for respiratory care.
The increased incidence of respiratory diseases such as Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA) are factors that are having a significant impact on the anaesthesia and respiratory devices market. The breathing apparatus is the dominant segment of the market due to the high prevalence rate of respiratory diseases. The hospital is the dominant segment as it is equipped with advanced apparatus. North America dominates the market in terms of revenue and will continue the same in the future.
MARKET RESTRAINTS:
However, a lack of awareness leading to a large underdiagnosed and undertreated population and the harmful effects of specific respiratory care devices on neonates have hampered market growth to an extent. In addition, the diagnostic industry as a whole and respiratory care diagnostic, in particular, is presently facing the challenge of a lack of reimbursements for various diagnostic tests. Reimbursement policies are dispersed in Europe and are available only for PAP devices and oral appliances in select countries (devices that are not covered by insurance have a low market share in the region). Also, the majority of countries in the Asian and RoW regions have negligible reimbursement coverage for respiratory care devices.
Low awareness of respiratory diseases; Despite the high prevalence of major respiratory diseases such as asthma and COPD, remains highly underdiagnosed and undertreated. It is particularly evident in developing economies due to the low awareness about these diseases and the unavailability of adequate resources to diagnose these diseases.
Ask here for more details@ https://www.visionresearchreports.com/report/enquiry/38758
Advent of Technologically Advanced Devices Provide Fresh Growth Prospects to Oxygen Delivery Devices
Further, advent of technologically respiratory devices, which offers efficient patient is projected to accelerate the market growth. Technologically advancement in delivery devices has resulted in integration of sensors coupled with pulse dose meters. These devices enable to regulate flow of the oxygen. Adoption of respiratory therapy is growing significantly. The growth rate is attributed to the potential benefits offered by the devices. These benefits include faster response rate, efficient dosing, controlled flow, and greater reliability and durability. These aforementioned factors are likely to propel the industry expansion process.
Growing prevalence of respiratory diseases such as sleep apnea and Chronic Obstructive Pulmonary disorder is anticipated to boost market growth. As per a report published by the WHO, nearly 64 million people across the globe suffers from mild to severe COPD. In addition, COPD is found to be third leading cause of death across the world. Rising demand for protracted treatment and emergency treatment associated with lung diseases in children and adults are likely to boost the market growth during the forecast period.
Further, respiratory therapeutics devices are preferred by medical professionals and physicians for treatment of various types of respiratory disorders. These devices provide immediate medical intervention in case of acute and chronic patient care.
North America to Top the Regional Charts in the Global Respiratory Devices Market over the Forecast Period
Owing to massive increase in geriatric population, North America will account for a sizeable share of the market. Besides, poor lifestyle choices such as tobacco consumption and smoking are contributing to growth in the regional market. Additionally, exposure to indoor and outdoor air pollution is also a major factor leading to increase in incidence of these diseases. Besides, a robust healthcare infrastructure and a favorable reimbursement policy are also supporting growth. Exposure to dust and fumes is also leading to growth in the market. Presence of strong players will also help the regional market for respiratory devices grow notably.
Asia Pacific (APAC) region is set to present market players with novel growth opportunities. The patient pool of patients suffering from respiratory illnesses in this region is high. Besides, a large number of older people exist in this region. Geriatric population will also be a notable growth factor in the European region. This region is also marked by presence of strong players and this is also leading to a higher growth curve over the period. Additionally, growing awareness regarding respiratory devices is also adding positively to this growth.
Key Players
The global respiratory devices market is fragmented owing to presence of a large number of market players. Some of the prominent names include Koninklijke Philips N.V., Hamilton Medical AG, Fisher & Paykel Healthcare Limited, ResMed, Inc., Invacare Corporation, Chart Industries Inc., Dräger Safety AG & Co. KGaA, Becton, Dickinson and Company, Masimo Corporation, and Medtronic plc. The other players operating in the industry include 3B Medical, Inc., Medline Industries Inc., Acare Technology Co., Ltd., Allied Healthcare Inc., Hill-Rom Holdings Inc., and Rotech Healthcare Inc.
Market Segmentation
By Product Type
- Therapeutic Devices
- Diagnostic & Monitoring Devices
By Therapeutic Devices
- Drug Delivery Devices
- Nebulizers
- Inhalers
- Mechanical Ventilators
- Invasive
- Non-Invasive
- Continuous Positive Airway Pressure
- Devices
- Disposables
- Resuscitators
- Reusable
- Disposables
- Humidifiers
- Airway Clearance Devices
- Oxygen Concentrators
- Consumables & Disposables
- Others
By Diagnostic & Monitoring Devices
- Pulse Oximeters
- Capnographs
- Spirometers
- Polysomnographs
- Peak Flow Meters
- Gas Analyzers
- Others
By Application
- Chronic Obstructive Pulmonary Disease
- Asthma
- Obstructive Sleep Apnea
- Respiratory Distress Syndrome
- Cystic Fibrosis
- Pneumonia
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38758
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333